SENOLYTIC THERAPEUTICS
Senolytic Therapeutics is a operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.
SENOLYTIC THERAPEUTICS
Industry:
Alternative Medicine Biopharma Biotechnology Medical Medical Device Pharmaceutical Robotics
Founded:
2017-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.senolytx.com
Total Employee:
1+
Status:
Active
Contact:
34607046707
Total Funding:
583.3 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Dyn DNS
Similar Organizations
Nanoform Therapeutics
Nanoform Therapeutics develops new generation of Bio-Pharmaceutical developmental or marketed drugs.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Timothy Cash Chief Scientific Officer @ Senolytic Therapeutics
Chief Scientific Officer
Brian Malone Chief Financial Officer @ Senolytic Therapeutics
Chief Financial Officer
Marc Ramis Castelltort Co-Founder and CEO @ Senolytic Therapeutics
Co-Founder and CEO
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Senolytic Therapeutics
Official Site Inspections
http://www.senolytx.com
- Host name: 104.21.39.148
- IP address: 104.21.39.148
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Senolytic Therapeutics"
Senolytic Therapeutics - Crunchbase Company Profile & Funding
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. Senolytic Therapeutics is a operator of a …See details»
Senolytic Therapeutics - LinkedIn
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. STX’s mission is to advance our portfolio of therapies to clinical...See details»
Senolytic Therapeutics - VentureRadar
"Senolytic Therapeutics (STX) is a biotech company developing novel medicines by targeting cellular senescence. We have developed a unique technological portfolio which is based on …See details»
Senolytic Therapeutics - Senolytics - lifespan
Senolytic Therapeutics is developing proprietary strategies to destroy the senescent cells that generate the senescence-associated secretory phenotype (SASP) and harm tissues, thus …See details»
Send in the senolytics | Nature Biotechnology
Nov 12, 2020 · Despite early failures in the clinic, the idea of anti-aging therapies that purge the body of dying cells is gaining traction with a raft of startups now focused on senescence. Unity …See details»
Senolytx Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Senolytx. Use the PitchBook Platform to explore the full profile.See details»
Senolytic Therapeutics - Craft
See insights on Senolytic Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Senolytx Therapeutics & How they Are Tackling Senescent Cells
Tim Cash is the Chief Scientific Officer of Senolytx Therapeutics, a biotech company developing novel medicines to improve and extend human lives by targeting senescent cells. One of the …See details»
Senolytic Therapeutics - Company Profile & Staff Directory
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. STX’s mission is to advance our portfolio of therapies …See details»
Senolytic drugs boost key protective protein - Mayo …
May 18, 2022 · Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that may protect older people against aspects of aging and a range of diseases. Their findings, which are published in eBioMedicine …See details»
Senolytx - SOMMa
Senolytx was born in the year 2017, fruit of the research led by Manuel Serrano. Selenolytic Therapeutics focuses on the removal of senescent cells for the treatment of diseases related …See details»
Senolytx - EU-Startups
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells. STX’s mission is to advance our portfolio of therapies …See details»
senolytx
먹튀검증이란 온라인 스포츠 배팅 사이트나 카지노 사이트 등에서 발생할 수 있는 먹튀 행위를 사전에 예방하고, 피해를 최소화하기 위해 사이트의 신뢰성과 안전성을 면밀히 조사하고 검토하는 과정을 …See details»
First-in-human trial of senolytic drugs encouraging - Medical Xpress
Jan 7, 2019 · UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly …See details»
#018: A Tour of All Senolytics Companies. - Longevity Marketcap
Dec 15, 2020 · Senolytx Therapeutics and How they Are Tackling Senescent Cells: Simple BioTech Podcast #1 General Notes Senolytic Therapeutics develops small molecule drug …See details»
Senolytic Therapeutics - Ventures & Markets - LONGECITY
Mar 14, 2019 · Senolytic Therapeutics - posted in Ventures & Markets: http://senolytx.com/ Our academic founders have played a key role in demonstrating that senescence occurs in …See details»
Senolytic drugs: from discovery to translation - PubMed
Senolytics are a class of drugs that selectively clear senescent cells (SC). The first senolytic drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis-driven …See details»
Senolytic Therapeutics | VentureRadar
Website: http://senolytx.com/ Develops novel medicines targeting senescent cells to extend healthy lives, focusing on age-related disorders including liver, lung, and kidney fibrosis. …See details»
First evidence that senolytics are effective at decreasing senescent ...
The increasing life expectancy of the world population has become an economic and global public health problem. Increased life expectancy tracks with a higher incidence of multiple chronic …See details»
Senolytic therapies for healthy longevity - PMC
In mice, the selective elimination of SNCs, commonly known as senolysis, extends median lifespan and prevents or attenuates various features of aging and age-related diseases such …See details»